Conference Reports for NATAP
EASL 45th Annual Meeting
April 14-18, 2010
Vienna, Austria
Back
 
Merck HCV Protease Inhibitor For Resistance
Reported by Jules Levin
EASL Apr 14-18 2010
Vienna Austria